Our website is made possible by displaying online advertisements to our visitors.
Please consider supporting us by disabling your ad blocker.
Zuclopenthixolum
 |
Cave: notitiae huius paginae nec praescriptiones nec consilia medica sunt. |
| Cognitores | |
|---|---|
| ChemSpider | 4470984 |
| PubChem | 5311507 |
| DrugBank | DB01624 |
| Natura chemica | |
| |
| |
| Formula chemica | C22H25ClN2OS |
| Massa molaris | 400.965 g/mol |
| Natura pharmacologica | |
| Codex ATC | N05AF05 (WHO) |
| Semivita biologica | 20 horae (per os) 19 dies (i.m.) |
| Metabolismus | iecore (hepaticus): CYP2D6, CYP3A4 |
| Excretio | faecibus |
| Ad usum therapeuticum | |
| Applicatio | per os, i.m. |
Zuclopenthixolum est medicamentum pharmaceuticum et antipsychoticum ad schizophreniam tractandam[1]. Substantia thioxanthenum antagonistaque receptoria dopamini D1 atque D2, adrenergica α1 et serotonini 5-HT2 obsidet. Frequenter effectus adversarii ut os siccum, ademptio conscientiae, inquies motuum sive nimium sive tarditas eorum observari possunt.
Zuclopenthixolum est Clopenthixoli cis-isomerus.
- ↑ Bryan EJ, Purcell MA, Kumar A (2017). "Zuclopenthixol dihydrochloride for schizophrenia". Cochrane Database Syst Rev 11: CD005474
Previous Page Next Page
